Vericity, Inc. (NASDAQ:VERY – Get Free Report) major shareholder Holdco L.P. Apex sold 11,373,352 shares of Vericity stock in a transaction that occurred on Friday, June 28th. The stock was sold at an average price of $11.43, for a total value of $129,997,413.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Vericity Stock Performance
Vericity stock remained flat at $11.43 during trading hours on Tuesday. The stock has a fifty day moving average price of $11.34 and a 200-day moving average price of $11.32. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.37. Vericity, Inc. has a 1 year low of $4.70 and a 1 year high of $12.14. The stock has a market cap of $170.08 million, a price-to-earnings ratio of -12.42 and a beta of 0.13.
Vericity (NASDAQ:VERY – Get Free Report) last released its earnings results on Wednesday, May 15th. The company reported ($0.37) earnings per share (EPS) for the quarter. Vericity had a negative return on equity of 12.99% and a negative net margin of 7.59%. The firm had revenue of $45.49 million during the quarter.
Hedge Funds Weigh In On Vericity
Vericity Company Profile
Vericity, Inc, together with its subsidiaries, provides life insurance protection products for the middle American market. The company operates through Agency and Insurance segments. The Agency segment sells life insurance products for unaffiliated insurance companies through its call center distribution platform, as well as through its independent agents and other marketing organizations.
Read More
- Five stocks we like better than Vericity
- 3 Ways To Invest In Coffee, Other Than Drinking It
- RXO Shares Surge Following New Acquisition Deal
- Investing in large cap stocks: Diving into big caps
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Vericity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vericity and related companies with MarketBeat.com's FREE daily email newsletter.